TITLE: PR1P, an inhaled novel short peptide for Acute Lung Injury and ARDS. TYPE OF AWARD: Drive TECHNOLOGY TYPE: Small Molecule CLINICAL AREA:  Lung INSTITUTION: Boston Children’s Hospital DESCRIPTION:ARDS is an acute inflammatory lung disease characterized by hypoxemia and multi-organ failure with mortality reaching 50%. It accounts for almost 200,000 ICU admissions yearly in the US and…

Read More